Literature DB >> 7981579

The influence of nicotine on performance, mood, and physiological parameters as related to smoking habit, gender, and suggestibility.

P Netter1, M J Müller, A Neumann, B Kamradik.   

Abstract

Based on previous observations that sensory suggestibility might be related to cholinergic drug effects, and that individual susceptibility to nicotine as defined by response differences to various doses is lower in males, nonsmokers, and highly suggestible subjects, the present study investigated whether nicotine serum blood levels, cardiovascular responses, and sensory suggestibility show differences according to gender and smoking habit, and whether differences in nicotine susceptibility measured by a discrimination task by subjective ratings on activation can be reproduced in the direction predicted by the previous data. In a double-blind threefold cross-over design 48 subjects divided according to smoking habit, gender, and sensory suggestibility were tested in balanced order under the influence of an oral dose of 0, 0.014, or 0.028 mg/kg body weight of nicotine. Results revealed higher serum levels of nicotine in males and smokers, a dose-dependent increase in heart rate and systolic and diastolic blood pressure, partly interacting with gender or smoking habit (females and nonsmokers showing larger increase with the low doses), and a change in suggestibility in the expected direction (decrease with the low dose, increase with the large one only in female nonsmokers). A fourfold interaction among dose, smoking habit, gender, and suggestibility for the discrimination task partly reproduced the observations of higher nicotine susceptibility in females and non-smokers, whereas suggestibility did not seem to reveal the expected changes. Also, on a subjective level larger doses were necessary to make male smokers feel activated, while the other groups showed the biphasic response pattern to the two nicotine doses. In conclusion, the data justify further research on the concept of nicotine susceptibility defined by biphasic effects of nicotine on vigilance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981579     DOI: 10.1007/BF00207480

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  1 in total

Review 1.  Clinical use of nicotine chewing-gum.

Authors:  M A Russell; M Raw; M J Jarvis
Journal:  Br Med J       Date:  1980-06-28
  1 in total
  6 in total

1.  Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women.

Authors:  Helen C Fox; Rajita Sinha
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

Review 2.  Benefits and limitations of drug studies in temperament research: biochemical responses as indicators of temperament.

Authors:  Petra Netter
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-04-19       Impact factor: 6.237

3.  Subjective response to nicotine by menstrual phase.

Authors:  Alicia M Allen; Scott Lunos; Stephen J Heishman; Mustafa al'Absi; Dorothy Hatsukami; Sharon S Allen
Journal:  Addict Behav       Date:  2014-12-16       Impact factor: 3.913

4.  Subjective, physiological, and cognitive responses to intravenous nicotine: effects of sex and menstrual cycle phase.

Authors:  Elise E DeVito; Aryeh I Herman; Andrew J Waters; Gerald W Valentine; Mehmet Sofuoglu
Journal:  Neuropsychopharmacology       Date:  2013-12-18       Impact factor: 7.853

5.  Subjective responses to intravenous nicotine: greater sensitivity in women than in men.

Authors:  Mehmet Sofuoglu; Marc Mooney
Journal:  Exp Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.157

Review 6.  Sex Differences in Behavioral Dyscontrol: Role in Drug Addiction and Novel Treatments.

Authors:  Marilyn E Carroll; John R Smethells
Journal:  Front Psychiatry       Date:  2016-02-08       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.